2003
DOI: 10.1542/peds.112.4.815
|View full text |Cite
|
Sign up to set email alerts
|

Risk of Anaphylaxis After Vaccination of Children and Adolescents

Abstract: Patients and health care providers can be reassured that vaccine-associated anaphylaxis is a rare event. Nevertheless, providers should be prepared to provide immediate medical treatment should it occur.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
141
3
14

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 298 publications
(160 citation statements)
references
References 16 publications
(13 reference statements)
2
141
3
14
Order By: Relevance
“…We also did not identify any case of anaphylaxis that could be attributed to Td vaccine in this study. This is consistent with a prior study in the VSD of children up to 17 years of age who were vaccinated during 1991 through 1997, which identified no cases of anaphylaxis following 152,636 Td vaccinations [19]. …”
Section: Discussionsupporting
confidence: 92%
“…We also did not identify any case of anaphylaxis that could be attributed to Td vaccine in this study. This is consistent with a prior study in the VSD of children up to 17 years of age who were vaccinated during 1991 through 1997, which identified no cases of anaphylaxis following 152,636 Td vaccinations [19]. …”
Section: Discussionsupporting
confidence: 92%
“…14 Previous studies have suggested that anaphylaxis after MMR is rare (approximated at 1.5-1.8 events per 1 million doses). [11][12][13] In our study, neither of the 2 cases identified via electronic data as having anaphylaxis after MMRV was ultimately confirmed as acute anaphylaxis according to chart review. Analyses comparing MMRV with MMR + V did not identify any statistical difference; however, given the low frequency of anaphylaxis after administration of measles-containing vaccines, continued monitoring for anaphylaxis after these vaccines is warranted.…”
Section: Discussionmentioning
confidence: 99%
“…The measles-mumps-rubella (MMR) vaccine has been associated with several safety outcomes, including febrile seizures, [1][2][3][4] fever, [5][6][7] immune thrombocytopenia purpura (ITP), [8][9][10] anaphylaxis, [11][12][13] and possibly arthritis/arthralgia. 14 After licensure of the combination measles-mumpsrubella-varicella vaccine (MMRV), the Advisory Committee on Immunization Practices recommended in 2006 that it preferred use of the MMRV over separate MMR and varicella (V) vaccines for the 2 recommended doses at 12 to 15 months and 4 to 6 years of age.…”
mentioning
confidence: 99%
“…1 The great variability found among total IgE values shows its low specificity for allergic diseases, in addition to its not being recommended for screening, once the increase in serum levels may occur in several clinical situations. 5 Frequency of positivity of specifi c IgE for dust mites (D. pteronyssinus) was higher in the control group (34.8%), suggesting that atopy is not related to anaphylaxis associated with vaccine.…”
Section: Resultsmentioning
confidence: 99%